Clinical Trials on HSV-1 in United Kingdom

Total 7378 results

University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing

Type 1 Diabetes

United Kingdom
Pfizer

Terminated

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

HIV-1

Spain, United Kingdom, Malaysia, United States, Portugal, Brazil, Germany, Italy, Poland, Puerto Rico, South Africa, Taiwan, Ukraine
University of Cambridge
Medical University of Graz; University Hospital Birmingham NHS Foundation Trust and other collaborators

Completed

24/7 Closed-loop in Older Subjects With Type 1 Diabetes (DAN06)

Hypoglycemia | Type 1 Diabetes Mellitus | Arrythmia

United Kingdom
Imperial College London

Completed

Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (FIRST1D)

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop in Adults With Type 1 Diabetes (CLEAR)

Type 1 Diabetes

United Kingdom
Imperial College London

Completed

Clinical Assessment of a Closed-loop Insulin Delivery System

Type 1 Diabetes Mellitus

United Kingdom
King's College London
Guy's and St Thomas' NHS Foundation Trust

Completed

Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De) (MultiPepT1De)

Type 1 Diabetes

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
Juvenile Diabetes Research Foundation; Wellcome Trust; University of Cambridge; National Institute for Health Research, United Kingdom

Completed

Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2 (DILT1D)

Type 1 Diabetes

United Kingdom
King's College Hospital NHS Trust

Unknown

Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?

Type 1 Diabetes Mellitus

United Kingdom
University of Edinburgh
NHS Lothian; DexCom, Inc.; Tandem Diabetes Care, Inc.; The Leona M. and Harry B...

Active, not recruiting

Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia | Hypoglycemia Unawareness | Glucagon Deficiency | Insulin Hypoglycemia

United Kingdom
Imperial College London
DexCom, Inc.

Recruiting

Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump (BELIEVE)

Type 1 Diabetes

United Kingdom
Cardiff University

Completed

Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 (EE-ASI-1)

Type 1 Diabetes

United Kingdom
Medtronic Diabetes

Completed

Safety and Effectiveness Study of a Closed Loop System Maintaining Patients' Glucose Levels During an Overnight Period

Type 1 Diabetes

United Kingdom
Liverpool John Moores University

Recruiting

Active Breaks in People With Type 1 Diabetes (EXTOD-Active)

Type 1 Diabetes

United Kingdom
University of Cambridge

Completed

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Type 1 Diabetes

United Kingdom
Liverpool John Moores University
Royal Liverpool University Hospital; University of Birmingham; University of... and other collaborators

Completed

HIT on Hypoglycaemic Risk in T1D

Type1diabetes

United Kingdom
Liverpool John Moores University
Royal Liverpool University Hospital; University of Birmingham; University of... and other collaborators

Completed

HIT on Hypoglycemic Risk in Type 1 Diabetes (T1D)

Type1diabetes

United Kingdom
Janssen Research & Development, LLC

Completed

Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets

HIV-1

United States
Newcastle University
Sanofi; Medtronic; Newcastle-upon-Tyne Hospitals NHS Trust; Newcastle Primary Care...

Completed

Prevention of Severe Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom
Sigilon Therapeutics, Inc.

Withdrawn

Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy

MPS I | MPS1-S | MPS1-HS

Brazil, United Kingdom
King's College London
King's College Hospital NHS Trust; Juvenile Diabetes Research Foundation; Guy... and other collaborators

Completed

Hypoglycaemia Awareness Restoration Programme (HARPdoc)

Hypoglycemia | Type 1 Diabetes Mellitus

United States, United Kingdom
Imperial College London

Completed

Advanced Bolus Calculator for Type 1 Diabetes (ABC4D) (ABC4D)

Type 1 Diabetes

United Kingdom
University of Edinburgh

Terminated

An ACT Based Application for Young People With Type 1 Diabetes (ACT)

Type 1 Diabetes

United Kingdom
Imperial College London

Completed

The Impact of a Predictive Hypoglycaemia Alert Function in Physical Activity for People With T1DM (PACE)

Type1diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop in Adolescents During Non-compliance Behaviours

Type 1 Diabetes

United Kingdom
Royal Devon and Exeter NHS Foundation Trust
King's College London; Leiden University Medical Center

Completed

Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production (TIGI)

Type 1 Diabetes Mellitus

Netherlands, United Kingdom
Pfizer

Completed

A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1

HIV-1

United Kingdom, South Africa, Australia, Canada, Italy, Poland, Switzerland, Argentina, Mexico
Alnylam Pharmaceuticals

Terminated

A Study of ALN-AAT02 in Healthy Participants and Participants With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease

ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease

United Kingdom
Imperial College London

Completed

Optimising Consultation Summaries to Promote Good Health (ONSET)

Type1 Diabetes

United Kingdom
Gilead Sciences

Completed

Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

HIV-1 Infection

Spain, United Kingdom, Italy, France, Belgium
Newcastle-upon-Tyne Hospitals NHS Trust

Recruiting

Global Registry for COL6-related Dystrophies

Bethlem Myopathy | Ullrich Congenital Muscular Dystrophy 1, Digenic, Col6A1/Col6A2 | Ullrich Congenital Muscular Dystrophy 1, Autosomal Recessive | Ullrich Congenital Muscular Dystrophy 1, Autosomal Dominant | Bethlem Myopathy 1, Autosomal Recessive | UCMD | BTHLM1

United Kingdom
Pfizer
ViiV Healthcare

Terminated

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

HIV-1

United States, United Kingdom, Portugal, Ukraine, Italy, Poland, Switzerland, Argentina, South Africa, Puerto Rico, Brazil, Malaysia
University of Southampton

Completed

Southampton Women's Survey COVID-19 Study (SWS_COVID-19)

Mental Health Wellness 1

United Kingdom
University of Hull

Completed

Environmental Effects Type 1 Diabetes Mellitus

Type1diabetes

United Kingdom
University of Dundee
Juvenile Diabetes Research Foundation

Completed

Use of Diazoxide in Acute Hypoglycaemia

Type 1 Diabetes

United Kingdom
University of Nottingham

Completed

Physical Activity in Children With Type 1 Diabetes Study

Physical Activity | Type 1 Diabetes Mellitus

United Kingdom
Imperial College London

Completed

Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant

Type 1 Diabetes | Type 2 Diabetes

United Kingdom
University of Edinburgh
NHS Lothian

Terminated

Energy Balance Following Islet Transplantation (EBFIT)

Type 1 Diabetes

United Kingdom
ANRS, Emerging Infectious Diseases
University College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaborators

Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

HIV-1-infection

France, United Kingdom, Switzerland
Northumbria University
Newcastle University

Completed

Post-exercise Appetite Responses in Type 1 Diabetes

Type 1 Diabetes Mellitus

United Kingdom
Janssen Pharmaceutica N.V., Belgium

Completed

Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets

HIV-1

United States, Spain
Imperial College London
Oxford Brookes University; Institut d'Investigació Biomèdica de Girona Dr.... and other collaborators

Completed

Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)

Type1 Diabetes Mellitus

United Kingdom
University of Dundee

Completed

DPP4inhibitors in Type 1 Diabetes

Type 1 Diabetes | Hypoglycaemia

United Kingdom
Daniela Elleri
Cambridge University Hospitals NHS Foundation Trust

Unknown

Closing the Loop in Young Children With Type 1 Diabetes

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust; Diabetes UK

Completed

Closing the Loop in Adults With Type 1 Diabetes (ANGELA01)

Type 1 Diabetes

United Kingdom
LifeScan

Completed

User Performance and System Accuracy Evaluations Using Glucose Adjustment

Type 1 Diabetes Mellitus

United Kingdom
University of Manchester

Completed

Randomised Controlled Trial of Method of Levels Cognitive Therapy

Depression | Anxiety | Mental Health Wellness 1

United Kingdom
Pfizer
ViiV Healthcare

Terminated

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

HIV-1

South Africa, Australia, United Kingdom, Canada, Italy, Poland, Switzerland, Mexico, Brazil
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop in Adults With Type 1 Diabetes - Alcohol Consumption (ANGELA02)

Type 1 Diabetes

United Kingdom

Clinical Trials on HSV-1 in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations